Brinton Pharmaceuticalson Monday said it is planning to export antiviral drugFavipiravir to Gulf countries and will launch it in India after getting approval from theDrugs Controller General of India(DCGI).
Favipiravir is a generic version of Avigan of Fujifilm Toyama Chemical Co Ltd, Japan, a subsidiary of Fujifilm Corporation,Brinton Pharmaceuticals said in a statement.
The drug will be marketed by the company under the brand name 'Faviton'and will be available in 200mg and 400mg tablets, itadded.
"The company will besupplying the drug to the Gulf region countries and will launch it in India after getting approval from DCGI,"Brinton PharmaceuticalsChairman and MDRahul Kumar Darda said.
Recently, the Task Force for Repurposing of Drugs for COVID-19 formed by the government, has classified Favipiravir and Tocilizumab as the drugs that have shown maximum readiness and potential in the fight against the disease, he added.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)